Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering Our Research GRIP Molecular Pharmacology Awards

Holaira press releases on targeted lung denervation: Loes Kistemaker

Holaira Announces First Scientific Presentations on Targeted Lung Denervation for COPD

Six Abstracts Delivered during ERS International Congress 2014

Minneapolis, MN, September 08, 2014 – Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, today announced the first scientific data presentations on the use of the Holaira™ Lung Denervation System in a procedure called Targeted Lung Denervation* (TLD), at the European Respiratory Society (ERS) International Congress 2014, Sept. 6-10, in Munich, Germany. Data presented included results of the first two multicenter feasibility studies of the Holaira System in patients with chronic obstructive pulmonary disease (COPD).

Last modified:04 February 2020 12.48 p.m.